Phase2 study of itraconazole,abraxane, carboplatin and avastin for advanced nonsquamous nonsmall cell lung cancer

Trial Profile

Phase2 study of itraconazole,abraxane, carboplatin and avastin for advanced nonsquamous nonsmall cell lung cancer

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 06 Oct 2015

At a glance

  • Drugs Bevacizumab (Primary) ; Paclitaxel (Primary) ; Carboplatin; Itraconazole
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Oct 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top